De Novo Donor Specific Antibodies in Pediatric Renal Transplant Recipients: Response to Therapy

被引：0
|
作者：
Tsai, E. [1 ]
Tzeng, J. [1 ]
Gjertson, D. [2 ]
Ettenger, R. [1 ]
Reed, E. [2 ]
机构：
[1] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A152
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [21] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [22] ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Schafer, Antonia
    Hadaya, Karine
    Villard, Jean
    Ferrari-Lacrai, Sylvie
    HLA, 2020, 95 (04) : 322 - 322
  • [23] Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients
    Sonia Solomon
    Adriana Colovai
    Marcela Del Rio
    Nicole Hayde
    Pediatric Nephrology, 2020, 35 : 261 - 270
  • [24] Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients
    Solomon, Sonia
    Colovai, Adriana
    Del Rio, Marcela
    Hayde, Nicole
    PEDIATRIC NEPHROLOGY, 2020, 35 (02) : 261 - 270
  • [25] What Stimulates the Development of De Novo Donor Specific Antibodies in Cardiac Transplant Recipients?
    Gupta, Richa
    Schlendorf, Kelly
    Fossey, Sallyanne
    Brinkley, Douglas M.
    Menachem, Jonathan N.
    Punnoose, Lynn R.
    Sacks, Suzanne Brown
    Ooi, Henry
    Wigger, Mark
    Zalawadiya, Sandip K.
    Lindenfeld, JoAnn
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S170 - S170
  • [26] Development of de novo donor-specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction
    Hod-Dvorai, Reut
    Lee, Ryan
    Muluhngwi, Penn
    Raijmakers, Mariella
    Shetty, Aneesha
    Tambur, Anat R.
    Ison, Michael G.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [27] BIOPSY FINDINGS AFTER DETECTION OF DE NOVO DONOR SPECIFIC ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS - A SINGLE CENTER EXPERIENCE
    Waldecker, C. B.
    Wunsch, A.
    Schenker, P.
    Seibert, F. S.
    Bauer, F.
    Babel, N.
    Rohn, B.
    Viebahn, R.
    Westhoff, T. H.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 41 - 41
  • [28] Carfilzomib versus Rituximab for Treatment of De Novo Donor Specific Antibodies in Lung Transplant Recipients
    Razia, D.
    Hu, C.
    Cherrier, L.
    Nasar, A.
    Walia, R.
    Tokman, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S112 - S113
  • [29] Treatment of De Novo Donor Specific Antibodies After Renal Transplant With IVIG.
    DeVos, J.
    Gaber, A.
    Patel, S.
    Islam, A.
    Teeter, L.
    Moore, L.
    Graviss, E.
    Skelton, A.
    Hong, D.
    Wolff, L.
    McGowan, C.
    Todd, E.
    Knight, R.
    TRANSPLANTATION, 2014, 98 : 138 - 138
  • [30] Treatment of De Novo Donor Specific Antibodies After Renal Transplant With IVIG.
    DeVos, J.
    Gaber, A.
    Patel, S.
    Islam, A.
    Teeter, L.
    Moore, L.
    Graviss, E.
    Skelton, A.
    Hong, D.
    Wolff, L.
    McGowan, C.
    Todd, E.
    Knight, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 138 - 138
12345